Allele-specific peptide ligand motifs of HLA-C molecules
about
A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanomaStructure of human histocompatibility leukocyte antigen (HLA)-Cw4, a ligand for the KIR2D natural killer cell inhibitory receptorDifferential binding to HLA-C of p50-activating and p58-inhibitory natural killer cell receptorsMass Spectrometry of Human Leukocyte Antigen Class I Peptidomes Reveals Strong Effects of Protein Abundance and Turnover on Antigen PresentationImmediate early and early lytic cycle proteins are frequent targets of the Epstein-Barr virus-induced cytotoxic T cell responseBypassing hybridoma technology: HLA-C reactive human single-chain antibody fragments (scFv) derived from a synthetic phage display library (HuCAL) and their potential to discriminate HLA class I specificities.Structural and regulatory diversity shape HLA-C protein expression levels.HLA-Cw*03-restricted CD8+ T-cell responses targeting the HIV-1 gag major homology region drive virus immune escape and fitness constraints compensated for by intracodon variationCytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motifUncovering the peptide-binding specificities of HLA-C: a general strategy to determine the specificity of any MHC class I moleculeT cell epitope clustering in the highly immunogenic BZLF1 antigen of Epstein-Barr virus.Activation-induced expression of CD137 permits detection, isolation, and expansion of the full repertoire of CD8+ T cells responding to antigen without requiring knowledge of epitope specificities.Melanocyte antigen triggers autoimmunity in human psoriasis.Overlapping epitopes in human immunodeficiency virus type 1 gp120 presented by HLA A, B, and C molecules: effects of viral variation on cytotoxic T-lymphocyte recognitionPsoriasis and other complex trait dermatoses: from Loci to functional pathways.Self and viral peptides can initiate lysis by autologous natural killer cellsHLA-B may be more protective against HIV-1 than HLA-A because it resists negative regulatory factor (Nef) mediated down-regulationPeptides isolated from HLA-Cw*0304 confer different degrees of protection from natural killer cell-mediated lysis.Characterization of the Canine MHC Class I DLA-88*50101 Peptide Binding Motif as a Prerequisite for Canine T Cell Immunotherapy.The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor.Irradiated sporozoite vaccine induces HLA-B8-restricted cytotoxic T lymphocyte responses against two overlapping epitopes of the Plasmodium falciparum sporozoite surface protein 2.The inter-locus recombinant HLA-B*4601 has high selectivity in peptide binding and functions characteristic of HLA-CThe direct binding of a p58 killer cell inhibitory receptor to human histocompatibility leukocyte antigen (HLA)-Cw4 exhibits peptide selectivity.HLA-C is the inhibitory ligand that determines dominant resistance to lysis by NK1- and NK2-specific natural killer cellsAllele-specific cytokine responses at the HLA-C locus: implications for psoriasis.Allelic variation in KIR2DL3 generates a KIR2DL2-like receptor with increased binding to its HLA-C ligandRelationship between HLA molecules and late restenosis after coronary stent placement.Strategy for monitoring T cell responses to NY-ESO-1 in patients with any HLA class I allele.HLA-C as a mediator of natural killer and T-cell activation: spectator or key player?Monoclonal antibodies to HLA-E bind epitopes carried by unfolded β2 m-free heavy chains.Cytotoxic potential of decidual NK cells and CD8+ T cells awakened by infections.HIV and host immunogenetics: unraveling the role of HLA-C.Critical role of endoplasmic reticulum aminopeptidase 1 in determining the length and sequence of peptides bound and presented by HLA-B27.A comprehensive analysis of constitutive naturally processed and presented HLA-C*04:01 (Cw4)-specific peptides.Immediate-early transactivator Rta of Epstein-Barr virus (EBV) shows multiple epitopes recognized by EBV-specific cytotoxic T lymphocytes.Unusual viral ligand with alternative interactions is presented by HLA-Cw4 in human respiratory syncytial virus-infected cells.Nef-mediated resistance of human immunodeficiency virus type 1 to antiviral cytotoxic T lymphocytes.Acute antibody-mediated renal allograft rejection associated with HLA-Cw17 antibody.Specific cytotoxic T lymphocytes recognize the immediate-early transactivator Zta of Epstein-Barr virus.Unveiling the Peptide Motifs of HLA-C and HLA-G from Naturally Presented Peptides and Generation of Binding Prediction Matrices.
P2860
Q24307739-E8CBFA31-221B-43C3-AA0E-FC2D87B14340Q24671977-04EC623E-789C-48A2-A894-AA02C3893E50Q28776435-930A0E50-9C9C-435A-9158-A7556E9DA3EDQ30002365-9B08BDB7-79CF-4455-88C8-3A9579EE4C83Q30442835-3832BC5F-5198-420E-9C3E-90747208A841Q30910034-E915DE50-C32B-49E3-9969-BC8E9494EFB6Q33851012-1B9ABE02-ADC2-45BD-A6A7-138B0984106BQ34190667-80A6F5CB-520C-403E-A8E3-DCEACE2A3921Q34199652-0FA74A58-9ED9-4555-8C17-AEBC992B396BQ34482335-6C3050F4-FBA3-42F3-B940-1DF2E1838CA7Q34992684-D71FA55F-E8A9-4E3F-9BB5-278FF612B28EQ35850673-508F5704-59AC-4F17-B8BC-F61F8B028B23Q35856465-FA762050-0A78-4431-9859-3CD15F884B33Q35876884-BF4C689F-512B-4979-8F19-39A465FBC836Q36043340-89FE369C-1A60-47AC-BCCC-0A515EFA4B1CQ36140540-6E68152D-F1D7-4993-88D7-24F8F775D8C7Q36170773-A142F33F-55AD-4E0A-B9F6-209B38235A24Q36183939-E41F72A1-42E9-4F8F-8B5F-D879321B6466Q36205561-FE264F98-1E47-46A9-AAB8-D73C51991DD0Q36364603-8064E382-3C83-4620-A385-E5F5559AF0D5Q36365487-E2993FD6-4585-4E37-975E-4D4A6FA63535Q36367077-D9172D1C-AF5F-4BB8-B6A0-72687ECB1FF2Q36377146-E7B0165E-1AC9-43CE-9323-D06C5435CCF5Q36738298-DB720D2A-12B6-4820-981D-D6856A5DD92DQ36751614-CB58F0B4-EF82-49CA-9924-F046B6B4314BQ36920302-910E24C4-E6C7-4FEE-B97A-0F12F6F53B55Q37056025-7B7002B4-2D53-4D1B-8F5F-24CF40ED68FAQ37266210-D1CF5DF8-9B10-423B-9B52-F34FE73C1473Q37847620-871F1803-052E-4E05-9A64-81E2F90D2941Q38873878-22FA46BD-A5CA-402B-932D-EE7C58C8261FQ38927520-B2AAFC91-5777-4C92-B414-3AEDEAC2D0BAQ38952775-AF8B0294-2E5A-438F-B23E-7D6EE40D47A9Q39026274-9BB9D2F4-D823-4BA1-AECE-36F2C7B6E697Q39036828-B610BFF6-A4EB-49C7-A41D-1EBC0FB7E2D6Q39581864-641D9A65-8CF6-44C2-8260-B9F91E366318Q39639898-F37E95D1-D7EC-4159-B285-3502B0C71CEAQ39682548-46038F9C-F860-42D9-BDEA-FE2EF29D9A05Q39720454-D041BDBB-A807-4434-980F-7ACBDA191945Q39871191-80AA25F2-D41B-4463-B7D4-48C7F2C5862EQ40048119-CB1D8B9C-1DAD-49A0-BBF8-70D256C0FAEF
P2860
Allele-specific peptide ligand motifs of HLA-C molecules
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
Allele-specific peptide ligand motifs of HLA-C molecules
@ast
Allele-specific peptide ligand motifs of HLA-C molecules
@en
type
label
Allele-specific peptide ligand motifs of HLA-C molecules
@ast
Allele-specific peptide ligand motifs of HLA-C molecules
@en
prefLabel
Allele-specific peptide ligand motifs of HLA-C molecules
@ast
Allele-specific peptide ligand motifs of HLA-C molecules
@en
P2093
P2860
P356
P1476
Allele-specific peptide ligand motifs of HLA-C molecules
@en
P2093
B Grahovac
D Schendel
H G Rammensee
O Rötzschke
S Stevanović
P2860
P304
12005-12009
P356
10.1073/PNAS.90.24.12005
P407
P577
1993-12-01T00:00:00Z